Dr Gordon Sanghera started his higher education in Cardiff, where his chemistry degree was a solid foundation for a PhD in bioelectronics at Cardiff with Prof JDR Thomas, and subsequently a career in the business of marrying biology, chemistry and electronics to create innovative breakthroughs in blood glucose sensing and DNA analysis.

Gordon along with Hagan Bayley and IP Group was co-founder of Oxford Nanopore. He was appointed CEO in June 2005. Oxford Nanopore aims to enable the analysis of any living thing, by any person, in any environment.  The Company’s first device, the MinION, is the only portable, real time DNA/RNA sequencer. In use in more than 70 countries, it is being used in the analysis of pathogens, human disease, crop science and environmental surveillance. The MinION is even being used to perform microbiology experiments on the international space station.

Oxford Nanopore now has more than 350 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The company has raised more than £451M to date and is currently well funded for the next phase of corporate development.

As Oxford Nanopore’s products scale upwards to be suitable for large scale population genomics projects, and downwards to potentially provide rapid tests at the point of care, what are the implications for industry, healthcare and even education?  And how should an emerging British technology company approach disrupting global markets?

Join us for this Cardiff University Innovation Network event, where Dr Sanghera will discuss these points and answer questions.

There will be a Q&A session following the presentation.

Networking – Canapes and networking will be available from 5.30pm.

Booking – Attendance at this event is free, but booking is required. Places will be allocated on a first come basis.

Registration – Registration will open at 5.30 pm. The session will start promptly at 6.00pm.